What to expect when starting a GLP-1 agonist like Tirzepatide or Semaglutide?

Individuals can expect several potential effects as their body adjusts to the medication.

Here are some common experiences:

Nausea is one of the most common side effects when initiating GLP-1 agonist therapy. It typically occurs in the first few weeks of treatment but often improves over time as the body adjusts. Eating smaller, more frequent meals and avoiding high-fat foods may help alleviate nausea.

Many people experience a reduction in appetite when starting a GLP-1 agonist, which can lead to weight loss. This effect is beneficial for individuals looking to manage their weight or improve glycemic control.

GLP-1 agonists work by increasing insulin secretion, decreasing glucagon secretion, and slowing gastric emptying, which helps regulate blood sugar levels. As a result, individuals may experience improved glycemic control, with reductions in fasting and postprandial blood glucose levels.

GLP-1 agonists are associated with weight loss in many individuals, primarily due to decreased appetite and reduced calorie intake. The weight loss effects can be significant, with some people experiencing substantial reductions in body weight over time.

Injection site reactions, such as redness, itching, or swelling, may occur at the site of injection. Rotating injection sites and using proper injection techniques can help minimize these reactions.

In addition to nausea, other gastrointestinal symptoms such as diarrhea, constipation, or abdominal discomfort may occur. These symptoms are usually mild to moderate in severity and tend to improve with continued use of the medication.

While GLP-1 agonists themselves do not typically cause hypoglycemia when used alone, they may increase the risk of hypoglycemia when used in combination with other diabetes medications such as insulin or sulfonylureas. Close monitoring of blood sugar levels is recommended, especially when starting or adjusting therapy. It’s important to note that individual responses to GLP-1 agonists can vary, and not everyone will experience the same side effects. Additionally, most side effects tend to diminish over time as the body adapts to the medication. If you have any concerns or experience severe or persistent side effects, it’s essential to discuss them with your healthcare provider for appropriate management and guidance.